Literature DB >> 33805751

Performance, Correlation and Kinetic Profile of Circulating Serum Fungal Biomarkers of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies.

Maria Siopi1, Stamatis Karakatsanis2, Christoforos Roumpakis3, Konstantinos Korantanis4, Elina Eldeik5, Helen Sambatakou5, Nikolaos V Sipsas4, Panagiotis Tsirigotis3, Maria Pagoni2, Joseph Meletiadis1.   

Abstract

As conventional microbiological documentation of invasive aspergillosis (IA) is difficult to obtain, serum fungal biomarkers are important adjunctive diagnostic tools. Positivity rates and the kinetic profiles of galactomannan (GM), 1,3-β-D-glucan (BDG) and Aspergillus DNA (PCR) were studied in high-risk patients with hematologic malignancies. GM, BDG and PCR data from serial serum specimens (n = 240) from 93 adult hematology patients with probable (n = 8), possible (n = 25) and no (n = 60) IA were retrospectively analyzed. Positivity rates and sensitivity/specificity/positive/negative predictive values (NPV) of each fungal biomarker alone and in combination were estimated. The three markers were compared head-to-head and correlated with various biochemical, demographic and patient characteristics. The positivity rates for patients with probable/possible/no IA were 88%/8%/0% for GM (X2 = 55, p < 0.001), 62%/46%/35% for BDG (X2 = 2.5, p = 0.29), 62%/33%/27% for PCR (X2 = 3.9, p = 0.15), 50%/4%/0% for GM + BDG and GM + PCR (X2 = 31, p < 0.001), 50%/8%/22% for BDG + PCR (X2 = 6.5, p = 0.038) and 38%/4%/0% for GM + BDG + PCR (X2 = 21, p < 0.001). Higher agreement (76%) and negative correlation (rs = -0.47, p = 0.0017) was found between GM index and PCR Ct values. The sensitivity and NPV was 45-55% and 90-92% when biomarkers assessed alone and increased to 75-90% and 93-97%, respectively when combined. Weak significant correlations were found between GM, PCR and BDG results with renal/liver function markers (r = 0.11-0.57) with most GM+ and PCR+ samples found in the first and second week of clinical assessment, respectively and BDG later on. Different positivity rates, time profiles and performances were found for the three biomarkers advocating the combination of GM with PCR for the early diagnosis of IA, whereas the high NPV of combined biomarkerscould help excluding IA.

Entities:  

Keywords:  biomarkers; diagnosis; hematology patients; invasive aspergillosis; kinetic profile

Year:  2021        PMID: 33805751      PMCID: PMC7999040          DOI: 10.3390/jof7030211

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN: 2309-608X


  38 in total

1.  Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.

Authors:  T Boch; B Spiess; O A Cornely; J J Vehreschild; P M Rath; J Steinmann; W J Heinz; J Hahn; S W Krause; M G Kiehl; G Egerer; T Liebregts; M Koldehoff; M Klein; F Nolte; M C Mueller; N Merker; S Will; M Mossner; H Popp; W-K Hofmann; M Reinwald; D Buchheidt
Journal:  Clin Microbiol Infect       Date:  2016-07-05       Impact factor: 8.067

Review 2.  Early diagnosis of invasive mould infections and disease.

Authors:  Frédéric Lamoth; Thierry Calandra
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

3.  Evaluation of Aspergillus PCR protocols for testing serum specimens.

Authors:  P Lewis White; Carlo Mengoli; Stéphane Bretagne; Manuel Cuenca-Estrella; Niklas Finnstrom; Lena Klingspor; Willem J G Melchers; Elaine McCulloch; Rosemary A Barnes; J Peter Donnelly; Juergen Loeffler
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

4.  Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies--high frequency of false-positive results and their analysis.

Authors:  Zdenek Racil; Iva Kocmanova; Martina Lengerova; Barbora Weinbergerova; Lucie Buresova; Martina Toskova; Jana Winterova; Shira Timilsina; Isa Rodriguez; Jiri Mayer
Journal:  J Med Microbiol       Date:  2010-05-20       Impact factor: 2.472

5.  Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.

Authors:  Helena Hammarström; Anna Stjärne Aspelund; Bertil Christensson; Claus Peter Heußel; Jenny Isaksson; Nahid Kondori; Lennart Larsson; Pawel Markowicz; Johan Richter; Christine Wennerås; Vanda Friman
Journal:  Mycoses       Date:  2018-06-26       Impact factor: 4.377

Review 6.  Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.

Authors:  Livio Pagano; Murat Akova; George Dimopoulos; Raoul Herbrecht; Lubos Drgona; Nicole Blijlevens
Journal:  J Antimicrob Chemother       Date:  2011-01       Impact factor: 5.790

7.  Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

Authors:  Christopher D Pfeiffer; Jason P Fine; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2006-04-14       Impact factor: 9.079

8.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

9.  Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum.

Authors:  C O Morton; J Loeffler; A De Luca; S Frost; C Kenny; S Duval; L Romani; T R Rogers
Journal:  J Med Microbiol       Date:  2009-12-24       Impact factor: 2.472

Review 10.  Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.

Authors:  P Lewis White; John R Wingard; Stéphane Bretagne; Jürgen Löffler; Thomas F Patterson; Monica A Slavin; Rosemary A Barnes; Peter G Pappas; J Peter Donnelly
Journal:  Clin Infect Dis       Date:  2015-06-25       Impact factor: 9.079

View more
  2 in total

1.  Evaluation of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay for the Diagnosis of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies.

Authors:  Maria Siopi; Stamatis Karakatsanis; Christoforos Roumpakis; Konstantinos Korantanis; Elina Eldeik; Helen Sambatakou; Nikolaos V Sipsas; Maria Pagoni; Maria Stamouli; Panagiotis Tsirigotis; Joseph Meletiadis
Journal:  Infect Dis Ther       Date:  2022-04-11

2.  Breakthrough Acute Necrotizing Invasive Fungal Rhinosinusitis by Alternariaalternata in a Patient with Acute Lymphoblastic Leukemia on Anidulafungin Therapy and Case-Based Literature Review.

Authors:  Giorgos Tyrellis; Maria Siopi; Danai Leventakou; Alexander Delides; Pavlos Maragkoudakis; George Korres; Christina Apostolopoulou; Alina-Roxani Gouloumi; Vasiliki Pappa; Spyros Pournaras; Ioannis Panayiotides; Joseph Meletiadis
Journal:  J Fungi (Basel)       Date:  2022-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.